CrossrefInfokaart
Population-Impact Model Estimating Clinical and Economic Outcomes Associated with Emicizumab in People with Moderate or Severe Hemophilia a in the US
Journal of Blood Medicine · 2026-11 · Volume 17 · 1-12
DOI: 10.2147/jbm.s619045 ↗Abstrakt
Kokkuvõte pole saadaval.
EUVIMED